Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Biosimilars Deals 2024
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
PipCast®
PTE
Trade Marks
Webinars

Home / News / Pearce IP Blog

Amneal publishes Q1 2022 financial results

by | May 4, 2022

Amneal published its Q1 2022 financial results, reporting a 1% increase YoY in net revenue.  Amneal announced that it plans to expand into high growth areas including biosimilars and injectables.

Print Page
Mail Article

Get our Pearce IP Blogs & BioBlast® sent directly to your inbox

Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.

Subscribe here

Our Latest News